Diminished dose nedaplatin combined with low-dose cisplatin as first-line therapy for advanced esophageal carcinoma: A randomized clinical trial

Tumor

Volumn 28, Issue 5, 2008, Pages 446-449

  Li, Su Yi ^a   Wan, Li Xin ^b   Ling, Yang ^c   Yuan, Bao Lan ^d   Gu, Ming ^e   Zhang, Feng Lin ^f   Li, Xing Ya ^g   Tong, Jian Dong ^h   Wu, Zheng Dong ⁱ   Liu, Lin ^a   Xu, Jian Zhong ^c   Wang, Zhu ^h  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b Nanyang Central Hospital   (China)

^c Department of Neurology   (China)

^d XUZHOU CENTRAL HOSPITAL   (China)

^e The Sixth Affiliated Hospital of Nantong University   (China)

^f Maanshan Clinical School of Anhui Medical University   (China)

^g ZHENGZHOU UNIVERSITY   (China)

^h Affiliated Hospital of Yangzhou University   (China)

ⁱ TAIZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Cisplatin; Drug therapy, combination; Esophageal neoplasms; Fluorouracil; Nedaplatin

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLIC ACID; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LEUKOPENIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METASTASIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 77953395009     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2008.05.020     Document Type: Article

References (7)

1. Chinese source.
2. TAGUCHI T, WAKUI A, NABEYA K, et al. A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointesl Cancer Study Group[J]. Gan To Kagaku Ryoho, 1992, 19(4):483-488.
3. SHIRAI T, HIROSE T, NODA M. Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer[J]. Lung Cancer, 2006, 52(2):181-187.
4. NISHIDA M, SATOH Y, NISHIDE K, et al. Phase I study of a combination chemotherapy of nedaplatin and cisplatin[J]. Gan To Kagaku Ryoho, 1999, 26(14):2209-2215.
5. HIRSCH FR, OSTERLIND K, JEPPESEN N, et al. Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients [J]. Ann Oncol, 2001, 12:647-653.
6. YOSHIOKA T, GAMOH M, SHINEHA R, et al. A new combination chemotherapy with cis-diammine-glycolato platinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers [J]. Intern Med, 1999, 38(11):844-848.
7. KANAI M, MATSUMOTO S, NISHIMURA T, et al. Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer[J]. Int J Clin Oncol, 2007, 12(3): 224-227.